Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | CDC25A | P30304 | 2/20 | 0.54 |
| ▸ | AKT1 | P31749 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH | P24723 | 1/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20090040 | 0.83 | LMNA (0.62) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL2118813 | 0.82 | LMNA (0.53) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL170993 | 0.81 | LMNA (0.56) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL1856364 | 0.80 | LMNA (0.51) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL30874576 | 0.79 | SMN1; SMN2 (0.51) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL139079 | 0.78 | SMN1; SMN2 (0.49) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL29613185 | 0.77 | LMNA (0.64) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL29613186 | 0.77 | LMNA (0.64) | LMNACDC25AAKT1ESR1ADORA3 | |
| SCHEMBL2118106 | 0.76 | SMN1; SMN2 (0.48) | LMNACDC25AAKT1ESR1ADORA3 | |
| Phosphocholine SCHEMBL10948480 | 0.76 | SMN1; SMN2 (0.46) | LMNACDC25AAKT1ESR1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121802-B1 | HIGH REFRACTIVE INDEX SILOXANE INSERT MATERIALS FOR EMBEDDED CONTACT LENSES | ALCON INC (CH) | 2024-07-17 | — | — | EP | claimed |
| EP-4076916-B1 | WETTABLE SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2024-06-12 | — | — | EP | claimed |
| EP-4369081-A2 | METHOD FOR PRODUCING AN OPHTHALMIC PRODUCT | Alcon Inc. (CH) | 2024-05-15 | — | — | EP | claimed |
| EP-4121801-B1 | INSERT MATERIALS WITH HIGH OXYGEN PERMEABILITY AND HIGH REFRACTIVE INDEX | ALCON INC (CH) | 2024-04-17 | — | — | EP | claimed |
| EP-4118134-B1 | PHOTOCHROMIC POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS | ALCON INC (CH) | 2024-02-28 | — | — | EP | claimed |
| US-11867874-B2 | Insert materials with high oxygen permeability and high refractive index | ALCON INC. (CH) | 2024-01-09 | — | — | US | claimed |
| WO-2023228055-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-30 | — | — | WO | claimed |
| US-20230374306-A1 | UV/HEVL-FILTERING CONTACT LENSES | ALCON INC. (CH) | 2023-11-23 | — | — | US | claimed |
| US-20230364832-A1 | METHOD FOR MAKING UV AND HEVL-ABSORBING OPHTHALMIC LENSES | ALCON INC. (CH) | 2023-11-16 | — | — | US | claimed |
| US-20230357478-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2023-11-09 | — | — | US | claimed |
| US-10962803-B2 | Contact lenses with a lubricious coating thereon | ALCON INC. (CH) | 2021-03-30 | — | — | US | claimed |
| EP-3774310-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2021-02-17 | — | — | EP | claimed |
| US-20200405747-A1 | OPHTHALMIC COMPOSITIONS | ALCON RESEARCH, LLC | 2020-12-31 | — | — | US | claimed |
| WO-2020261185-A1 | OPHTHALMIC COMPOSITIONS | ALCON INC. (CH) | 2020-12-30 | — | — | WO | claimed |
| US-20190300654-A1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON RESEARCH, LTD. | 2019-10-03 | — | — | US | claimed |
| US-20190263971-A1 | SILICONE HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2019-08-29 | — | — | US | claimed |
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | KCI CO., LTD. (KR) | 2014-09-25 | — | — | US | claimed |
| EP-0537972-B1 | Treating solution for contact lenses | NOF CORP (JP) | 1996-07-10 | — | — | EP | claimed |
| US-5461433-A | Cleaning contact lens by immersing in solution containing copolymer where one of the monomers contains phsophate and tertiary ammonium groups | NOF CORPORATION (JP) | 1995-10-24 | — | — | US | claimed |
| EP-0537972-A1 | Treating solution for contact lenses | NOF CORPORATION (JP) | 1993-04-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140288259-A1 | SURFACE-MODIFIED ULTRAVIOLET BLOCKING POWDER AND ULTRAVIOLET BLOCKING COMPOSITION INCLUDING SAME | C1QBP, PCTP, CD59 | LMNA 1745/4885CDC25A 654/4885AKT1 3056/4885 |
| US-20200405747-A1 | OPHTHALMIC COMPOSITIONS | B4GALT1, B3GAT3, ALG1 | LMNA 1627/4885CDC25A 1260/4885AKT1 729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.